{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:59:11Z","timestamp":1780109951419,"version":"3.54.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.juro.2016.10.089","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T20:30:24Z","timestamp":1478032224000},"page":"1041-1047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4-Kallikrein Marker Panel"],"prefix":"10.1097","volume":"197","author":[{"given":"Eric H.","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Urology, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald L.","family":"Andriole","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. David","family":"Crawford","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery, University of Colorado, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D.","family":"Sjoberg","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Clinical Chemistry Service, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Assel","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Clinical Chemistry Service, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Vickers","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Clinical Chemistry Service, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Lilja","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Surgery and Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom"},{"name":"Department of Translational Medicine, Lund University, Sk\u00e5ne University Hospital, Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2016.10.089_bib1","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0022-5347(17)35233-3","article-title":"Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men","volume":"151","author":"Catalona","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2016.10.089_bib2","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2016.10.089_bib3","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2016.10.089_bib4","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1001\/jama.293.17.2095","article-title":"20-Year outcomes following conservative management of clinically localized prostate cancer","volume":"293","author":"Albertsen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2016.10.089_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1741-7015-6-19","article-title":"A panel of kallikreins markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Goteborg, Sweden","volume":"6","author":"Vickers","year":"2008","journal-title":"BMC Med"},{"key":"10.1016\/j.juro.2016.10.089_bib6","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2009.24.1968","article-title":"Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication","volume":"28","author":"Vickers","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2016.10.089_bib7","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/cncr.25010","article-title":"Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated PSA: data from the European Randomized Study of Prostate Cancer screening in Gothenburg, Sweden","volume":"116","author":"Vickers","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2016.10.089_bib8","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/sj.bjc.6605815","article-title":"A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands","volume":"103","author":"Gupta","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2016.10.089_bib9","doi-asserted-by":"crossref","first-page":"djv095","DOI":"10.1093\/jnci\/djv095","article-title":"Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study","volume":"107","author":"Bryant","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2016.10.089_bib10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.eururo.2013.04.040","article-title":"Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: results from the European Randomized Study of Screening for Prostate Cancer section Rotterdam","volume":"64","author":"Carlsson","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2016.10.089_bib11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2012.02.054","article-title":"International variation in prostate cancer incidence and mortality rates","volume":"61","author":"Center","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2016.10.089_bib12","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jnci\/93.5.388","article-title":"Racial and ethnic differences in advanced-stage prostate cancer: the prostate cancer outcomes study","volume":"93","author":"Hoffman","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2016.10.089_bib13","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1002\/cncr.27379","article-title":"Explaining racial differences in prostate cancer mortality","volume":"118","author":"Taksler","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2016.10.089_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/jnci\/djs486","article-title":"Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations","volume":"105","author":"Haiman","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2016.10.089_bib15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/clinchem\/41.8.1115","article-title":"Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum","volume":"41","author":"Mitrunen","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.juro.2016.10.089_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jim.2011.04.006","article-title":"Immunoassay for the discrimination of free prostate-specific antigen (fPSA) forms with internal cleavages at Lys(145) or Lys(146) from fPSA without internal cleavages at Lys(145) or Lys(146)","volume":"369","author":"Peltola","year":"2011","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.juro.2016.10.089_bib17","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1373\/clinchem.2004.035253","article-title":"Development of sensitive immunoassays for free and total human glandular kallikrein 2","volume":"50","author":"V\u00e4is\u00e4nen","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.juro.2016.10.089_bib18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2164\/jandrol.107.003616","article-title":"Beta-microseminoprotein in serum correlates with the levels in seminal plasma of young, healthy males","volume":"29","author":"Valtonen-Andre","year":"2008","journal-title":"J Androl"},{"key":"10.1016\/j.juro.2016.10.089_bib19","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1021\/ac061201+","article-title":"Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab\u2019)2 fragments","volume":"15","author":"V\u00e4is\u00e4nen","year":"2006","journal-title":"Anal Chem"},{"key":"10.1016\/j.juro.2016.10.089_bib20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading for prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.juro.2016.10.089_bib21","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.urology.2014.02.035","article-title":"Prostate cancer prevention trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer","volume":"83","author":"Ankerst","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.juro.2016.10.089_bib22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"10.1016\/j.juro.2016.10.089_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12916-015-0296-5","article-title":"Prostate-specific antigen-based screening: controversy and guidelines","volume":"13","author":"Kim","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.juro.2016.10.089_bib24","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S1470-2045(15)00361-7","article-title":"Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study","volume":"16","author":"Gr\u00f6nberg","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.juro.2016.10.089_bib25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.eururo.2014.10.021","article-title":"A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer","volume":"68","author":"Parekh","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2016.10.089_bib26","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.eururo.2011.11.029","article-title":"Risk-based prostate cancer screening","volume":"61","author":"Zhu","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2016.10.089_bib27","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/sj.bjc.6605422","article-title":"Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer","volume":"101","author":"Heijnsdijk","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2016.10.089_bib28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa1201637","article-title":"Quality-of-life effects of prostate-specific antigen screening","volume":"367","author":"Heijnsdijk","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2016.10.089_bib29","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/cncr.28790","article-title":"Multiparametric magnetic resonance imaging outperforms the prostate cancer prevention trial risk calculator in predicting clinically significant prostate cancer","volume":"120","author":"Salami","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2016.10.089_bib30","series-title":"Overview of Race and Hispanic Origin, 2010. 2010 Census Briefs","author":"Humes","year":"2011"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534716316330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534716316330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2016.10.089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T08:56:13Z","timestamp":1718873773000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2016.10.089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1016\/j.juro.2016.10.089"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2016.10.089","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4-Kallikrein Marker Panel","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2016.10.089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}